<DOC>
	<DOCNO>NCT02031640</DOCNO>
	<brief_summary>This Phase 3 , randomize , placebo-controlled , double-blind , double-dummy , parallel-group , 12-week study male female patient , 12 year age old , persistent asthma .</brief_summary>
	<brief_title>A Safety Efficacy Study Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler ( BAI ) Metered-Dose Inhaler ( MDI ) Participants &gt; =12 Years Old With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Severity disease : The patient persistent asthma , force expiratory volume 1 second ( FEV1 ) 40 % 85 % value predict age , height , sex , race per National Health Nutrition Examination Survey ( NHANES III ) ( Hankinson et al 1999 ) reference value screen visit . Current asthma therapy : The patient must stable dose inhale corticosteroid ( ICS ) least 440 mcg/day fluticasone propionate equivalent minimum 4 week screen visit , inhale corticosteroid/longacting beta2agonist ( ICS/LABA ) combination minimum 4 week prescreening visit . Reversibility disease : The patient demonstrate least 12 % reversibility FEV1 least 200 mL increase baseline FEV1 ( patient age 18 older ) within 30 minute 24 inhalation albuterol/salbutamol hydrofluoroalkane ( HFA ) MDI ( 90 mcg exactuator ) equivalent screen visit If female , patient currently pregnant , breast feeding , attempt become pregnant . If childbearing potential , negative serum pregnancy test willing commit use consistent acceptable method birth control . Other criterion apply , please contact investigator information The patient history lifethreatening asthma , define protocol asthma episode require intubation and/or associate hypercapnea , respiratory arrest , hypoxic seizure . The patient pregnant lactating , plan become pregnant study period 30 day patient 's last studyrelated visit ( eligible patient , applicable ) . Eligible female patient unwilling employ appropriate contraceptive measure ensure pregnancy occur study exclude . Any patient become pregnant study withdrawn study . The patient know hypersensitivity corticosteroid excipients study drug rescue medication formulation . The patient currently smoke smoke history 10 packyears ( packyear define smoke 1 pack cigarettes/day 1 year ) . The patient asthma exacerbation require oral corticosteroid within 30 day screen visit , hospitalization asthma within 2 month screen visit . The patient historical current evidence clinically significant disease . Significant disease define disease medical judgment investigator would put safety patient risk participation could affect efficacy safety analysis disease/condition worsen study . Other criterion apply , please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>breath-actuated inhaler</keyword>
	<keyword>metered-dose inhaler</keyword>
</DOC>